| Literature DB >> 34730110 |
Irena Pastar1, Andrew P Sawaya1, Jelena Marjanovic1, Jamie L Burgess1, Natasa Strbo2, Katelyn E Rivas2, Tongyu C Wikramanayake1, Cheyanne R Head1, Rivka C Stone1, Ivan Jozic1, Olivera Stojadinovic1, Eran Y Kornfeld1, Robert S Kirsner1,3, Hadar Lev-Tov1,3, Marjana Tomic-Canic1.
Abstract
Impaired wound healing associated with recurrent Staphylococcus aureus infection and unresolved inflammation are hallmarks of nonhealing diabetic foot ulcers (DFUs). Perforin-2, an innate immunity molecule against intracellular bacteria, limits cutaneous infection and dissemination of S. aureus in mice. Here, we report the intracellular accumulation of S. aureus in the epidermis of DFUs with no clinical signs of infection due to marked suppression of perforin-2. S. aureus residing within the epidermis of DFUs triggers AIM2 inflammasome activation and pyroptosis. These findings were corroborated in mice lacking perforin-2. The effects of pyroptosis on DFU clinical outcomes were further elucidated in a 4-week longitudinal clinical study in patients with DFUs receiving standard care. Increased AIM2 inflammasome and ASC-pyroptosome coupled with induction of IL-1β were found in nonhealing DFUs compared with healing DFUs. Our findings revealed that perforin-2 suppression, intracellular S. aureus accumulation, and associated induction of pyroptosis contribute to healing inhibition and prolonged inflammation in patients with DFUs.Entities:
Keywords: Dermatology; Diabetes; Inflammation; Molecular pathology; Skin
Mesh:
Substances:
Year: 2021 PMID: 34730110 PMCID: PMC8670843 DOI: 10.1172/JCI133727
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808